BARBA, MADDALENA
 Distribuzione geografica
Continente #
NA - Nord America 649
EU - Europa 270
AS - Asia 35
AF - Africa 13
SA - Sud America 5
OC - Oceania 1
Totale 973
Nazione #
US - Stati Uniti d'America 638
IT - Italia 132
FR - Francia 70
DE - Germania 23
CA - Canada 11
GB - Regno Unito 9
IN - India 8
ZA - Sudafrica 8
CN - Cina 7
KR - Corea 7
FI - Finlandia 6
UA - Ucraina 6
NL - Olanda 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
SE - Svezia 4
CL - Cile 3
ES - Italia 3
NG - Nigeria 3
ID - Indonesia 2
PH - Filippine 2
PL - Polonia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
BR - Brasile 1
EC - Ecuador 1
EG - Egitto 1
GH - Ghana 1
HK - Hong Kong 1
JP - Giappone 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
Totale 973
Città #
Santa Cruz 78
Rome 66
Fairfield 55
Seattle 54
Buffalo 53
Ashburn 37
Cambridge 28
Houston 28
Woodbridge 23
Wilmington 21
Chicago 20
Des Moines 11
Boardman 10
Los Angeles 9
Bremen 8
Paris 8
Ann Arbor 7
Dallas 7
Muizenberg 7
Ottawa 6
Aviano 5
Clearwater 5
Helsinki 5
San Diego 5
Cedar Knolls 4
Phoenix 4
San Francisco 4
San Jose 4
Stockholm 4
Toronto 4
Andover 3
Council Bluffs 3
Las Vegas 3
London 3
Milan 3
Pietra Ligure 3
Rende 3
Seoul 3
Amsterdam 2
Bathinda 2
Burgos 2
Büdelsdorf 2
Columbus 2
Fleming Island 2
Fort Myers 2
Gangnam-gu 2
Ipswich 2
Naples 2
New York 2
Padova 2
Port Harcourt 2
Reston 2
Riva 2
Santiago 2
Scranton 2
Shenyang 2
Warsaw 2
Yellow Springs 2
A Coruña 1
Atlanta 1
Auckland 1
Austin 1
Baotou 1
Beijing 1
Birmingham 1
Boydton 1
Brookline 1
Cairo 1
Castel Maggiore 1
Cerveteri 1
Cesano Boscone 1
Chandanagar 1
Chandigarh 1
Chandler 1
Chennai 1
Ciciliano 1
Crugers 1
Deiva Marina 1
Dong-gu 1
Exeter 1
Fiumicino 1
Florence 1
Frankfurt Am Main 1
Frankfurt am Main 1
Gimhae 1
Grosseto 1
Grumo Nevano 1
Guangzhou 1
Gunzenhausen 1
Henderson 1
Iesi 1
Irgoli 1
Jacksonville 1
Kassel 1
Kirkland 1
Lake Forest 1
Lappeenranta 1
Laurel 1
Levallois-perret 1
Lisbon 1
Totale 686
Nome #
Metabolic determinants and anthropometric indicators impact clinical-pathological features in epithelial ovarian cancer patients, file e3835315-c032-15e8-e053-a505fe0a3de9 127
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study, file e3835321-b842-15e8-e053-a505fe0a3de9 110
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study, file e3835323-6a17-15e8-e053-a505fe0a3de9 101
Autoantibodies specific to ERa are involved in tamoxifen resistance in hormone receptor positive breast cancer, file e3835324-0148-15e8-e053-a505fe0a3de9 93
Biomarkers of response and resistance to CDK4/6 inhibitors in breast cancer: hints from liquid biopsy and microRNA exploration, file 44358de5-5bd3-471b-af6e-a66928cf6783 79
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome, file e3835321-f215-15e8-e053-a505fe0a3de9 74
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer, file e3835322-acbf-15e8-e053-a505fe0a3de9 63
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e3835322-d440-15e8-e053-a505fe0a3de9 59
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials, file e383532b-35b3-15e8-e053-a505fe0a3de9 57
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes, file e3835328-2476-15e8-e053-a505fe0a3de9 45
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial, file e383532d-1991-15e8-e053-a505fe0a3de9 39
How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature, file ec84f899-29d3-4fa2-93db-079cbd6da340 34
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience, file 45f6d0d2-c79f-4c8b-a254-29e4d8fe77a0 33
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives, file e383532e-e0a7-15e8-e053-a505fe0a3de9 17
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file e383532e-fa2b-15e8-e053-a505fe0a3de9 15
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives, file 28d040f3-75f0-4669-9847-0444212b96d4 12
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file 414ca0a4-8e30-4a18-94ef-25ad85b00f14 11
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience, file e3835321-b0d8-15e8-e053-a505fe0a3de9 11
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study, file a4d4c711-927f-4aaf-9908-49639ba20321 10
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e383532a-6618-15e8-e053-a505fe0a3de9 8
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden, file e3835329-7ad4-15e8-e053-a505fe0a3de9 5
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience, file e383531d-6cf8-15e8-e053-a505fe0a3de9 4
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors, file 5c52434d-69f0-4045-aa86-68e5004acaa2 3
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study, file 9dc11e0f-7d44-475a-8534-d3594138c914 2
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists, file e383532f-2e8a-15e8-e053-a505fe0a3de9 2
Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial, file e3835315-7bd4-15e8-e053-a505fe0a3de9 1
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy, file e383532d-1993-15e8-e053-a505fe0a3de9 1
Totale 1.016
Categoria #
all - tutte 2.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 3 8 12
2019/2020140 4 4 6 6 15 9 20 17 21 14 16 8
2020/2021162 16 9 8 14 4 15 6 6 23 38 16 7
2021/2022203 8 4 15 5 20 7 7 14 9 8 71 35
2022/2023266 18 10 58 44 20 27 16 11 4 33 23 2
2023/2024213 12 11 22 18 40 28 25 39 11 7 0 0
Totale 1.016